We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVEO icon
3876
Civeo
CVEO
$345M
$69K ﹤0.01%
4,543
+9
+0.2% +$159
TH icon
3877
Target Hospitality
TH
$1.51B
$69K ﹤0.01%
+10,153
New +$76.8K
TIGR
3878
UP Fintech Holding
TIGR
$876M
$69K ﹤0.01%
+16,356
New +$74.9K
ABEO icon
3879
Abeona Therapeutics
ABEO
$366M
$67K ﹤0.01%
1,180
-138
-10% -$10.3K
ARDX icon
3880
Ardelyx
ARDX
$1.22B
$67K ﹤0.01%
14,375
+1,256
+10% +$4.36K
NINE
3881
DELISTED
Nine Energy Service
NINE
$67K ﹤0.01%
10,942
+666
+6% +$6.52K
ADVM
3882
DELISTED
Adverum Biotechnologies
ADVM
$66K ﹤0.01%
1,220
+19
+2% +$2.14K
CRBP icon
3883
Corbus Pharmaceuticals
CRBP
$166M
$65K ﹤0.01%
448
-76
-15% -$13.2K
CDMO
3884
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$65K ﹤0.01%
12,444
+419
+3% +$2.6K
FTR
3885
DELISTED
Frontier Communications Corp.
FTR
$65K ﹤0.01%
74,864
+6,697
+10% +$7.53K
PVLA
3886
Palvella Therapeutics
PVLA
$1.99B
$64K ﹤0.01%
+237
New +$91.8K
KDMN
3887
DELISTED
Kadmon Holdings, Inc.
KDMN
$64K ﹤0.01%
25,410
-1,875
-7% -$4.66K
LAC
3888
DELISTED
Lithium Americas Corp. Common Shares
LAC
$64K ﹤0.01%
21,138
SCOR icon
3889
Comscore
SCOR
$106M
$62K ﹤0.01%
1,634
-648
-28% -$37.4K
XXII
3890
22nd Century Group
XXII
$1.38M
0
ATEC icon
3891
Alphatec Holdings
ATEC
$1.46B
$60K ﹤0.01%
+11,894
New +$61.8K
AT
3892
DELISTED
Atlantic Power Corporation
AT
$59K ﹤0.01%
25,418
+6,787
+36% +$16.3K
HSDT icon
3893
Solana Company
HSDT
$96.3M
0
MEET
3894
DELISTED
The Meet Group, Inc. Common Stock
MEET
$58K ﹤0.01%
17,723
+5,706
+47% +$19.8K
SNCR
3895
DELISTED
Synchronoss Technologies
SNCR
$57K ﹤0.01%
+1,186
New +$80.4K
CBL
3896
DELISTED
CBL& Associates Properties, Inc.
CBL
$57K ﹤0.01%
44,460
+2,689
+6% +$2.81K
SENS icon
3897
Senseonics Holdings Inc
SENS
$263M
$56K ﹤0.01%
2,845
-1,440
-34% -$34.9K
ADMA icon
3898
ADMA Biologics
ADMA
$1.96B
$54K ﹤0.01%
+12,162
New +$50.8K
CHMA
3899
DELISTED
Chiasma, Inc. Common Stock
CHMA
$54K ﹤0.01%
+10,983
New +$62.3K
CTSO icon
3900
Cytosorbents Corp
CTSO
$22.7M
$53K ﹤0.01%
10,620
-5,131
-33% -$29.8K

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.